ArticleFrontiers in immunology2025

Integration of anti-PD-1 antibody into chemotherapeutic regimens improved the outcome of aggressive NK cell leukemia: a single-center retrospective real-world analysis.

Kai Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.